IPO Rush: 13 Public Issues Worth ₹14,700 Crore to Hit Dalal Street This Week; 11 Firms Set for Market Debut
A busy week on Dalal Street as 13 IPOs worth over ₹14,700 crore open, with Wakefit Innovations and Corona Remedies leading market action from December 8.
Investors gear up as 13 IPOs worth ₹14,700 crore hit Dalal Street this week.
Dalal Street is gearing up for another action-packed week as 13 initial public offerings (IPOs) open for subscription starting December 8, collectively aiming to raise over ₹14,700 crore. Of this, nearly ₹14,338 crore will be mobilised through mainboard IPOs, marking one of the busiest fundraising weeks of the year.
Among the mainboard entries, Wakefit Innovations, the Bengaluru-based home and furnishings brand, and pharmaceutical company Corona Remedies will kick off the action on December 8. Wakefit has set its price band at ₹185–195 per share and plans to raise ₹1,289 crore, while Corona Remedies has fixed a price band of ₹1,008–1,062 per share, targeting ₹655.4 crore at the upper end.
The momentum continues on December 10, when Nephrocare Health Services and Park Medi World launch their public issues. Nephrocare has announced a price band of ₹438–460 per share, and Park Medi World will open at ₹154–162 per share.
In addition to the IPOs, 11 companies are scheduled to make their stock market debut this week, adding to the activity across the primary market.
Overall, the upcoming week is expected to keep investors busy, with strong pipeline activity reflecting momentum in India’s IPO landscape.
